Fatty acid-enriched extracts from H. illucens larvae, particularly AWME3, exhibited potent antibacterial activity against colistin-resistant A. baumannii, likely through membrane-disruptive mechanisms. These findings highlight the potential of insect-derived bioactive compounds as sustainable alternatives for managing MDR pathogens.
Mohamed et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: